Guardant Health
GH
#979
Rank
A$34.74 B
Marketcap
A$258.93
Share price
2.54%
Change (1 day)
145.05%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -A$0.67 Billion

According to Guardant Health 's latest financial reports the company's current earnings are A$1.18 Billion. In 2025 the company made an earning of -A$0.6 Billion, an increase over its 2024 earnings that were of -A$0.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.67 Billion13.05%
2025 -A$0.6 Billion-4.03%
2024 -A$0.62 Billion-9.12%
2023 -A$0.68 Billion-26.73%
2022 -A$0.93 Billion69.96%
2021 -A$0.55 Billion56.35%
2020 -A$0.35 Billion252.69%
2019 -A$98.88 Million-17.22%
2018 -A$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-A$12.71 Million-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-A$0.36 Billion-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA